Back to results
US 8,785,464 B2Granted
Pyrimidine derivatives that inhibit FAK/PTK2
AssigneeBoehringer Ingelheim International GmbH
InventorsHeinz Stadtmueller, Bodo Betzemeier, Ioannis Sapountzis
Life of this patent
Estimating the term…
Abstract
The present invention includes compounds of general formula (1) wherein A, X, R1 and R2 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
Claims3
A compound selected from the group consisting of:
- 1
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 48
- 49
- 50
- 51
- 52
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 68
- 69
- 70
- 73
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- or a pharmaceutically acceptable salt thereof.
66 more elements
Dependencies are inferred from the claim text.